Skip to content

Clinical trials

Terminated Pleural Effusion, Malignant trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pleural Effusion, Malignant Status: Terminated Country / region: United States Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20061
20092
20151
20161
20171
20191
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated9

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Abramson Cancer Center at Penn Medicine1
Amgen1
Duke University1
Fox Chase Cancer Center1
Fujirebio Diagnostics, Inc.1
M.D. Anderson Cancer Center1
Peter Bushunow MD1
UNC Lineberger Comprehensive Cancer Center1
University of Pennsylvania1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pleural Effusion, Malignant9
Carcinoma, Non-Small-Cell Lung4
Lung Neoplasms3
Neoplasm Metastasis2
Pleural Diseases2
Pleural Effusion2
Anemia1
Neoplasms1
Pleural Neoplasms1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.